buy sell hold 

 

UOB KAYHIAN DBS VICKERS

 

Thai Beverage (THBEV SP)

FY20: Cost Control Pays Off

 

THBEV announced reported FY20 net profit of Bt22.8b, down 2.2% yoy, above expectations. Full-year dividend is Bt0.46/share (FY19: Bt0.48). Spirits volume grew by a strong 9% yoy in 4QFY20. The group benefitted from well-managed SG&A costs, which look set to continue in the near term, given lower levels of on-premise activities. We also look forward to a gradual recovery at Sabeco. Maintain BUY with a 9% higher target price of S$0.85.

 

Read More ...

 

 

Jumbo Group

Weak outlook, lofty valuations

 

Investment Thesis: Maintain FULLY VALUED, TP S$0.21. Jumbo is over-priced at 27x FY21F PE. At the current share price, the market is expecting earnings to stage a strong turnaround to S$10.3m profit based on a normalised 20x forward PE.

 

Read More ...

 UOB KH

 KGI 

Genting Malaysia (GENM MK)

3Q20: Impressive GGR Recovery Supports Generous Dividends


GENM’s 3Q20 results met expectations. Revenue declined 46% yoy and EBITDA plunged 55% yoy, reflecting the partial impact of the COVID-19 lockdown at its gaming properties and largely reduced gaming capacity. A major and highly impressive surprise was Genting Highlands regaining much of its GGR led by VIP volumes. Investors will now appreciate the earnings recovery potential and the sustainability of its lush dividends. Maintain BUY with a higher target price of RM3.40.

Read more... 
 

- Q & M Dental Group (Q&M) has remained resilient with its dental and medical services through Covid-19. It continues to be the bread and butter of the Group, as its network of clinics dominate the private dental healthcare space.

- New venture into medical technology firm Acumen Diagnostics Pte Ltd to provide a strong but short-term boost to earnings within the next two years. Given the continued need for Covid-19 testing regardless of the availability of vaccines, we are confident on the outlook of Acumen Diagnostics in the short-term.

- We initiate on Q&M with OUTPERFORM, and a 12-month target price (TP) of S$0.54. Q&M continues to generate stable and resilient earnings, and we foresee no material changes in or threats to its market share in the private dental space in the medium term.

Read more.... 


LionelLim8.16Check out our compilation of Target Prices




Share Prices

Counter NameLastChange
AEM Holdings3.720-0.080
Avi-Tech Electronics0.280-
Best World1.760-0.030
Broadway Ind0.120-
China Sunsine0.390-0.015
DISA0.003-
Food Empire0.640-
Fortress Minerals0.375-
Geo Energy Res0.350-
Golden Energy0.7950.005
GSS Energy0.048-0.001
InnoTek0.455-0.015
ISDN Holdings0.400-0.005
ISOTeam0.090-
IX Biopharma0.125-0.002
Jiutian Chemical0.080-
KSH Holdings0.345-0.005
Leader Env0.056-
Medtecs Intl0.136-0.002
Meta Health0.025-
Nordic Group0.475-
Oxley Holdings0.150-0.001
REX International0.225-0.010
Riverstone0.6250.010
Sinostar PEC0.166-0.029
Southern Alliance Mining0.410-0.090
Straco Corp.0.395-
Sunpower Group0.2800.010
The Trendlines0.092-0.001
Totm Technologies0.102-
UG Healthcare0.190-0.004
Uni-Asia Group0.810-
Wilmar Intl4.070-0.020
Yangzijiang Shipbldg1.390-0.010

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 1499 guests and no members online